Atrial Fibrillation in Patients with Very High Risk for Stroke and Adverse Events-Insights from the Observational ARENA Study

Overview

Journal J Clin Med

Specialty General Medicine

Date 2024 Nov 27

PMID 39597789

Authors

Angelika Alonso

Ibrahim Akin

Matthias Hochadel

Martin Borggrefe

Hendrik Lesch

Armin Grau

Ralf Zahn

Patrick Lugenbiel

Christopher Jan Schwarzbach

Tim Sueselbeck

Jochen Senges

Christian Fastner

Affiliations

Soon will be listed here.

Abstract

Atrial fibrillation (AF) is a major cause of stroke. An individual risk estimation remains challenging, as AF patients with and without cerebrovascular event (CVE) may differ in yet unknown factors beyond those covered by the CHADS-VASc score. We aimed to identify differences between AF patients with and without CVE with regard to AF characteristics and treatment, vascular risk factors and comorbidities, prognosis and outcome. We analyzed patients included in the Atrial Fibrillation Rhine-Neckar Region (ARENA) Project, an observational cohort study of patients with AF. Patients were recruited by their general practitioner or during a hospital stay and were divided into two groups for the present analysis: patients with acute CVE at baseline and/or history of CVE versus patients without CVE. Follow-up at 1 year was conducted via phone call. Of 2061 included patients (60.6% male), 292 (14.2%) belonged to the CVE group. Patients in the CVE group were older (mean age 74.6 versus 71.7 years; < 0.001) and had a higher CHADS-VASc score at baseline (5.3 versus 3.3 points; < 0.001) based on the preceding CVE. Moreover, patients with either acute or chronic CVE had a larger left atrium (median diameter 47/46 mm versus 44 mm; = 0.001). Patients with acute CVE had structural heart diseases ( < 0.001) less frequently than patients with previous or without CVE. Mortality at 1 year (HR 1.95; 95%-CI 1.37-2.78) was more frequent in the CVE group ( < 0.001). During 1-year of follow-up, stroke occurred more frequently in survivors with CVE (2.9% versus 0%; < 0.001). AF patients with CVE have a significantly worse prognosis than AF patients without CVE. Atrial structural remodeling, underlying cardiovascular disease, stroke-induced heart injury and further unidentified factors may account for this finding. Characterization of AF patients including echocardiography to detect atrial structural remodeling may be helpful in risk stratification beyond classical scores.

References

Marrouche N, Kheirkhahan M, Brachmann J . Catheter Ablation for Atrial Fibrillation with Heart Failure. N Engl J Med. 2018; 379(5):492. DOI: 10.1056/NEJMc1806519. View

Hart R . Atrial fibrillation and stroke prevention. N Engl J Med. 2003; 349(11):1015-6. DOI: 10.1056/NEJMp038123. View

Packer D, Mark D, Lee K . Catheter Ablation Compared With Drug Therapy for Atrial Fibrillation-Reply. JAMA. 2019; 322(11):1106. DOI: 10.1001/jama.2019.10688. View

Hirsh B, Copeland-Halperin R, Halperin J . Fibrotic atrial cardiomyopathy, atrial fibrillation, and thromboembolism: mechanistic links and clinical inferences. J Am Coll Cardiol. 2015; 65(20):2239-51. DOI: 10.1016/j.jacc.2015.03.557. View

Tomasdottir M, Friberg L, Hijazi Z, Lindback J, Oldgren J . Risk of ischemic stroke and utility of CHA DS -VASc score in women and men with atrial fibrillation. Clin Cardiol. 2019; 42(10):1003-1009. PMC: 6788468. DOI: 10.1002/clc.23257. View

Zhou Z, You S, Sakamoto Y, Xu Y, Ding S, Xu W . Covert Cerebrovascular Changes in People With Heart Disease: A Systematic Review and Meta-Analysis. Neurology. 2024; 102(8):e209204. DOI: 10.1212/WNL.0000000000209204. View

Baumann S, Grau A, Senges J, Schneider S, Alonso A, Katus H . [ARENA-Project atrial fibrillation in the Rhein-Neckar region]. Herz. 2019; 45(7):689-695. DOI: 10.1007/s00059-018-4772-5. View

Szymanski F, Lip G, Filipiak K, Platek A, Hrynkiewicz-Szymanska A, Opolski G . Stroke Risk Factors Beyond the CHA₂DS₂-VASc Score: Can We Improve Our Identification of "High Stroke Risk" Patients With Atrial Fibrillation?. Am J Cardiol. 2015; 116(11):1781-8. DOI: 10.1016/j.amjcard.2015.08.049. View

Chen L, Leening M, Norby F, Roetker N, Hofman A, Franco O . Carotid Intima-Media Thickness and Arterial Stiffness and the Risk of Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study, Multi-Ethnic Study of Atherosclerosis (MESA), and the Rotterdam Study. J Am Heart Assoc. 2016; 5(5). PMC: 4889172. DOI: 10.1161/JAHA.115.002907. View

10.

Nielsen P, Skjoth F, Overvad T, Larsen T, Lip G . Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHADS-VA Score Rather Than CHADS-VASc?. Circulation. 2018; 137(8):832-840. DOI: 10.1161/CIRCULATIONAHA.117.029081. View

11.

Bernstein R, Kamel H, Granger C, Piccini J, Sethi P, Katz J . Effect of Long-term Continuous Cardiac Monitoring vs Usual Care on Detection of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease: The STROKE-AF Randomized Clinical Trial. JAMA. 2021; 325(21):2169-2177. PMC: 8170544. DOI: 10.1001/jama.2021.6470. View

12.

. Silent brain infarction in nonrheumatic atrial fibrillation. EAFT Study Group. European Atrial Fibrillation Trial. Neurology. 1996; 46(1):159-65. DOI: 10.1212/wnl.46.1.159. View

13.

Michel P, Odier C, Rutgers M, Reichhart M, Maeder P, Meuli R . The Acute STroke Registry and Analysis of Lausanne (ASTRAL): design and baseline analysis of an ischemic stroke registry including acute multimodal imaging. Stroke. 2010; 41(11):2491-8. DOI: 10.1161/STROKEAHA.110.596189. View

14.

Chiang C, Naditch-Brule L, Murin J, Goethals M, Inoue H, ONeill J . Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry. Circ Arrhythm Electrophysiol. 2012; 5(4):632-9. DOI: 10.1161/CIRCEP.112.970749. View

15.

Sposato L, J Hilz M, Aspberg S, Murthy S, Bahit M, Hsieh C . Post-Stroke Cardiovascular Complications and Neurogenic Cardiac Injury: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020; 76(23):2768-2785. DOI: 10.1016/j.jacc.2020.10.009. View

16.

Overvad T, Nielsen P, Larsen T, Sogaard P . Left atrial size and risk of stroke in patients in sinus rhythm. A systematic review. Thromb Haemost. 2016; 116(2):206-19. DOI: 10.1160/TH15-12-0923. View

17.

Brambatti M, Connolly S, Gold M, Morillo C, Capucci A, Muto C . Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation. 2014; 129(21):2094-9. DOI: 10.1161/CIRCULATIONAHA.113.007825. View

18.

Dretzke J, Chuchu N, Agarwal R, Herd C, Chua W, Fabritz L . Predicting recurrent atrial fibrillation after catheter ablation: a systematic review of prognostic models. Europace. 2020; 22(5):748-760. PMC: 7203634. DOI: 10.1093/europace/euaa041. View

19.

Sanna T, Diener H, Passman R . Cryptogenic stroke and atrial fibrillation. N Engl J Med. 2014; 371(13):1261. DOI: 10.1056/NEJMc1409495. View

20.

Hindricks G, Potpara T, Dagres N, Arbelo E, Bax J, Blomstrom-Lundqvist C . 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the.... Eur Heart J. 2020; 42(5):373-498. DOI: 10.1093/eurheartj/ehaa612. View